AbbVie
AbbVie Inc. is a prominent biopharmaceutical company based in the United States that was publicly traded and established in 2013. The company's inception stemmed from its spin-off from the renowned Abbott Laboratories.
Background
AbbVie's establishment in 2013 was a strategic move by Abbott Laboratories to separate its research-driven pharmaceutical business from its diversified medical products. The decision to spin off AbbVie aimed at allowing both entities to focus more exclusively on their individual business strategies and growth potentials.
Core Areas of Focus
AbbVie is committed to harnessing groundbreaking science to tackle some of the world's most complex and critical health challenges. Its primary areas of therapeutic focus include:
The company consistently invests in robust R&D initiatives to propel the boundaries of medicine and offer promising treatment avenues.
Notable Products
AbbVie's portfolio boasts several groundbreaking and life-transforming drugs. Some of its flagship products include:
- Humira - An anti-inflammatory drug used for various conditions such as rheumatoid arthritis, psoriasis, and Crohn’s disease.
- Imbruvica - An oral, once-daily therapy mainly for patients with specific types of leukemia and lymphoma.
- Viekira Pak - A drug regimen used for the treatment of hepatitis C.
Global Presence
With a commitment to addressing complex health challenges, AbbVie has expanded its reach across the globe. It conducts business in more than 75 countries, ensuring that its life-saving treatments are accessible to patients worldwide.
Corporate Social Responsibility
Driven by its mission to have a remarkable impact on people's lives, AbbVie is heavily invested in community-centric programs, sustainable business practices, and initiatives aimed at reducing its carbon footprint.
See Also
References
- [1] AbbVie's Official History. Accessible at: https://www.abbvie.com/our-story.html
- [2] AbbVie's Therapeutic Areas of Focus. Retrieved from: https://www.abbvie.com/therapeutic-focus.html
- [3] AbbVie's Global Operations. Referenced from: https://www.abbvie.com/global-operations.html
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD